Table of contents

Therapeutics

• Magnesium sulphate prevented eclampsia in women with pre-eclampsia (1 January, 2003)
• Simvastatin reduced mortality and vascular events (1 January, 2003) Free
• Antioxidant vitamins did not reduce death, vascular events, or cancer in high risk patients (1 January, 2003)
• Oestrogen plus progestin was not effective for long term secondary prevention of coronary heart disease in postmenopausal women (1 January, 2003)
• Long term oestrogen plus progestin increased venous thromboembolism and biliary tract surgery in postmenopausal women (1 January, 2003)
• Self management with the Angina Plan reduced anxiety, depression, angina attacks, and use of medication (1 January, 2003)
• Review: β blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction (1 January, 2003)
• Coumadin alone or aspirin plus coumadin reduced coronary events and death after acute myocardial infarction or unstable angina (1 January, 2003)
• Involving patients with type 2 diabetes, hypertension, and hyperlipidaemia in disease management improved outcomes (1 January, 2003)
• Review: primary prevention strategies do not improve contraceptive use or reduce pregnancies in adolescents (1 January, 2003)
• Lansoprazole reduced recurrence of ulcer complications in long term use of low dose aspirin (1 January, 2003)
• Noninvasive Helicobacter pylori testing was as effective as endoscopy for managing dyspepsia

  (1 January, 2003)
• Helicobacter pylori eradication improved dyspepsia symptoms

  (1 January, 2003)
• Risperidone was safe and effective for short term treatment of children with autism and serious behavioural disturbances (1 January, 2003)
• Cognitive behavioural therapy delivered by nurses improved insight and overall symptomatology in schizophrenia (1 January, 2003)
• Treatment of scalp lacerations with a hair apposition technique reduced scarring, pain, and procedure duration compared with suturing (1 January, 2003)
• Tonsillectomy and adenotonsillectomy showed modest benefits in children moderately affected with recurrent throat infection (1 January, 2003)